Protection against COVID-19: beyond antibodies

Lancet Infect Dis. 2022 Jan;22(1):4-5. doi: 10.1016/S1473-3099(21)00561-2. Epub 2021 Sep 9.

Authors

Marcus Vinícius Guimarães Lacerda¹, Daniel Youssef Bargieri²

Affiliations

¹ Instituto de Pesquisa Clínica Carlos Borborema, Fundação de Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil; Fundação Oswaldo Cruz, Instituto Leônidas e Maria Deane, Manaus 69040-000, Brazil. Electronic address: marcuslacerda.br@gmail.com.
² Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, Brazil.

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Neutralizing
COVID-19*
Humans
SARS-CoV-2
Spike Glycoprotein, Coronavirus

Substances

Antibodies, Neutralizing
Spike Glycoprotein, Coronavirus